ストックスクリーナーアプリを入手
115.19
0.11%
0.13
アフターアワーズ：
115.00
-0.19
-0.16%
Repligen Corp (RGEN) 最新ニュース
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference - Yahoo Finance
Repligen Corp stock (US7607591002): ESG progress and growth focus draw fresh attention - AD HOC NEWS
Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks - Yahoo Finance
Repligen keeps factories on 100% renewable power, cuts water use 14% - Stock Titan
Repligen Corp (RGEN) Stock Up 4.2% and Still Undervalued -- GF S - GuruFocus
Repligen shares jump 4.1% as investors buy the dip after a sharp selloff; prior guidance update and short-covering may be factors - Quiver Quantitative
Repligen Jumps 5.4% Amid Sector-Wide Rally - AlphaStreet
Why Repligen (RGEN) Stock Is Trading Up Today - Yahoo Finance
Repligen (RGEN) director granted RSUs and options in Form 4 filing - Stock Titan
Repligen (NASDAQ: RGEN) director receives new RSU and stock option awards - Stock Titan
Repligen (RGEN) director Rohin Mhatre receives RSU and option grants - Stock Titan
Repligen (RGEN) director Margaret Pax receives new RSU and stock option awards - Stock Titan
Repligen (RGEN) director granted RSUs and stock options as compensation - Stock Titan
Repligen (RGEN) director receives new RSU and stock option grants - Stock Titan
Repligen Corp stock (US7607591002): bioprocessing specialist back in focus after latest earnings - AD HOC NEWS
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know - Yahoo Finance
Repligen Corp stock (US7607591002): RBC upgrade and Q1 2026 earnings put bioprocessing specialist ba - AD HOC NEWS
BNY Mellon Mid Cap Multi-Strategy Fund's Repligen Corp(RGEN) Holding History - GuruFocus
Repligen Corp. 2026 Annual Meeting Results: Voting Outcomes & Key Shareholder Decisions - Minichart
Repligen shareholders approve board nominees and executive pay at annual meeting - Investing.com
Repligen (NASDAQ: RGEN) holders back board, auditor and pay plan - Stock Titan
5 Revealing Analyst Questions From Repligen’s Q1 Earnings Call - Yahoo Finance
Repligen (RGEN) Receives Positive Coverage from RBC Capital - GuruFocus
Repligen stock coverage resumed at RBC with outperform rating By Investing.com - Investing.com Nigeria
Repligen stock coverage resumed at RBC with outperform rating - Investing.com
Repligen Corp stock (US7607591002): bioprocessing specialist after earnings and 52?week low - AD HOC NEWS
Repligen CorporationCommon Stock (NQ: RGEN - FinancialContent
Repligen Corp (RGEN) Stock Down 5.8% -- Now Undervalued? GF Scor - GuruFocus
Repligen Corporation stock hits 52-week low at $109.44 - Investing.com
Repligen Opens Bioprocessing Innovation Center in the Netherlands - HarianBasis.co
Barclays Maintains an “Overweight Rating” on Repligen Corporation (RGEN) - Insider Monkey
TradingKey - TradingKey
Repligen Q1 2026 slides: revenue jumps 15%, China sales double - Investing.com
Earnings call transcript: Repligen’s Q1 2026 results exceed expectations - Investing.com
Repligen Corp at Leerink Global Healthcare Conference Transcript - GuruFocus
Repligen (RGEN) director adds 2,434 shares via option exercise - Stock Titan
Repligen (RGEN) CPO has 334 RSU shares withheld to cover taxes - Stock Titan
Investors can watch Repligen CFO live from a May 12 healthcare conference - Stock Titan
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference - Yahoo Finance
Repligen (NASDAQ: RGEN) posts Q1 2026 growth but books Polymem sale loss - Stock Titan
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises - Yahoo Finance
Repligen Corporation (NASDAQ:RGEN) Q1 2026 Earnings Call Transcript - Insider Monkey
Repligen Reshapes Operations And China Reach As Valuation Signals Upside - Yahoo Finance
Repligen Q1 Earnings Call Highlights - Yahoo Finance
Repligen Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Repligen (RGEN) Shares Skyrocket, What You Need To Know - Barchart.com
Repligen (RGEN) Q1 2026 Earnings Call Transcript - The Globe and Mail
Repligen Q1 2026 slides: analytics surge drives 23% EPS growth - Investing.com
Earnings call transcript: Repligen beats Q1 2026 forecasts, stock rises By Investing.com - Investing.com Canada
Earnings call transcript: Repligen beats Q1 2026 forecasts, stock rises - Investing.com
Repligen (RGEN) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Repligen Corp (NASDAQ:RGEN) Sees Pre-Market Gain After Q1 Earnings Beat Offsets Slight Revenue Miss - ChartMill
Repligen’s (NASDAQ:RGEN) Q1 CY2026 Sales Beat Estimates - Yahoo Finance
Q1 2026 Repligen Corp Earnings Call Transcript - GuruFocus
Repligen: Q1 Earnings Snapshot - Barchart.com
1.04%
0.04%
大文字化:
|
ボリューム (24 時間):